211 related articles for article (PubMed ID: 9753230)
1. Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide.
Hahm KB; Lee KJ; Kim JH; Cho SW; Chung MH
Dig Dis Sci; 1998 Sep; 43(9 Suppl):72S-77S. PubMed ID: 9753230
[TBL] [Abstract][Full Text] [Related]
2. Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
Kang DW; Noh YN; Hwang WC; Choi KY; Min do S
Biochem Pharmacol; 2016 Aug; 113():36-44. PubMed ID: 27265143
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation and oxidative stress: the smoking gun for Helicobacter pylori-induced gastric cancer?
Hardbower DM; de Sablet T; Chaturvedi R; Wilson KT
Gut Microbes; 2013; 4(6):475-81. PubMed ID: 23811829
[TBL] [Abstract][Full Text] [Related]
4. Pathways of Gastric Carcinogenesis,
Toh JWT; Wilson RB
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899442
[No Abstract] [Full Text] [Related]
5. Peripheral lymphocyte DNA damage and oxidative status after eradication therapy in patients infected with Helicobacter pylori.
Dulger AC; Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Celik H; Kocyigit A
Pol Arch Med Wewn; 2011 Dec; 121(12):428-32. PubMed ID: 22012003
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer.
Shimizu T; Marusawa H; Watanabe N; Chiba T
Gastroenterol Clin North Am; 2015 Sep; 44(3):625-38. PubMed ID: 26314672
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori-Mediated Genetic Instability and Gastric Carcinogenesis.
Shimizu T; Chiba T; Marusawa H
Curr Top Microbiol Immunol; 2017; 400():305-323. PubMed ID: 28124159
[TBL] [Abstract][Full Text] [Related]
8. [The cytoprotective drug rebamipide in therapy for inflammatory and erosive-ulcerative lesions of the gastrointestinal tract].
Yakovenko EP; Agafonova NA; Ivanov AN; Yakovenko AV; Aldiyarova MA; Volosheinikova TV; Grigoryeva YV; Soluyanova IP
Ter Arkh; 2016; 88(4):88-92. PubMed ID: 27070169
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Helicobacter pylori and host genetic variants in gastric carcinogenesis.
Jia ZF; Zhang SL; Cao XY; Zhou BS; Jiang J
Future Oncol; 2016 Sep; 12(18):2127-34. PubMed ID: 27324311
[TBL] [Abstract][Full Text] [Related]
10. Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase.
Chaturvedi R; de Sablet T; Asim M; Piazuelo MB; Barry DP; Verriere TG; Sierra JC; Hardbower DM; Delgado AG; Schneider BG; Israel DA; Romero-Gallo J; Nagy TA; Morgan DR; Murray-Stewart T; Bravo LE; Peek RM; Fox JG; Woster PM; Casero RA; Correa P; Wilson KT
Oncogene; 2015 Jun; 34(26):3429-40. PubMed ID: 25174398
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori-Induced DNA Damage Is a Potential Driver for Human Gastric Cancer AGS Cells.
Shi Y; Wang P; Guo Y; Liang X; Li Y; Ding S
DNA Cell Biol; 2019 Mar; 38(3):272-280. PubMed ID: 30657337
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study.
Kamada T; Sato M; Tokutomi T; Watanabe T; Murao T; Matsumoto H; Manabe N; Ito M; Tanaka S; Inoue K; Shiotani A; Akiyama T; Hata J; Haruma K
Biomed Res Int; 2015; 2015():865146. PubMed ID: 26060821
[TBL] [Abstract][Full Text] [Related]
13. A lucid review of Helicobacter pylori-induced DNA damage in gastric cancer.
Fu L; Xie C
Helicobacter; 2019 Oct; 24(5):e12631. PubMed ID: 31295756
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to
Xie C; Li N; Wang H; He C; Hu Y; Peng C; Ouyang Y; Wang D; Xie Y; Chen J; Shu X; Zhu Y; Lu N
Gut Microbes; 2020 Nov; 11(6):1567-1589. PubMed ID: 32588736
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori: a ROS-inducing bacterial species in the stomach.
Handa O; Naito Y; Yoshikawa T
Inflamm Res; 2010 Dec; 59(12):997-1003. PubMed ID: 20820854
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species and gastric carcinogenesis: The complex interaction between Helicobacter pylori and host.
Wu S; Chen Y; Chen Z; Wei F; Zhou Q; Li P; Gu Q
Helicobacter; 2023 Dec; 28(6):e13024. PubMed ID: 37798959
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin Inhibits Helicobacterium pylori Infection-Induced Gastric Carcinogenic Signaling by Blocking Inflammation, Apoptosis, and Mitogen-Activated Protein Kinase Events in Gastric Epithelial-1 Cells.
Ouyang Y; Li L; Ling P
J Environ Pathol Toxicol Oncol; 2020; 39(1):77-88. PubMed ID: 32479014
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk Between DNA Damage and Inflammation in the Multiple Steps of Gastric Carcinogenesis.
Sokolova O; Naumann M
Curr Top Microbiol Immunol; 2019; 421():107-137. PubMed ID: 31123887
[TBL] [Abstract][Full Text] [Related]
19. At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.
Dalal RS; Moss SF
J Leukoc Biol; 2014 Aug; 96(2):213-24. PubMed ID: 24823809
[TBL] [Abstract][Full Text] [Related]
20. p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis?
Li N; Xie C; Lu NH
Oncotarget; 2016 Oct; 7(40):66276-66286. PubMed ID: 27556187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
